(Q46132173)

19 December 2017

title

Transsphenoidal microsurgical therapy of prolactinomas: initial outcomes and long-term results (English)

1 reference

19 December 2017

0 references

Tyrrell JB

1

1 reference

19 December 2017

Lamborn KR

2

1 reference

19 December 2017

Hannegan LT

3

1 reference

19 December 2017

Applebury CB

4

1 reference

19 December 2017

Wilson CB

5

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

19 December 2017

published in

Neurosurgery

1 reference

19 December 2017

volume

44

1 reference

19 December 2017

issue

2

1 reference

19 December 2017

page(s)

254-61; discussion 261-3

1 reference

19 December 2017

Gradual recovery of lactotroph responsiveness to dynamic stimulation following surgical removal of prolactinomas: long-term follow-up studies

cites work

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199902000-00006

Galactorrhoea: Successful Treatment with Reduction of Plasma Prolactin Levels by Brom-ergocryptine

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199902000-00006

Prolactinomas and resistance to dopamine agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199902000-00006

Dopaminergic treatments for hyperprolactinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199902000-00006

Should dopamine agonist treatment for prolactinomas be life-long?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199902000-00006

Transsphenoidal microsurgery for prolactin-secreting pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199902000-00006

Results of surgical management of 319 pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199902000-00006

Therapeutic applications of bromocriptine in endocrine and neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199902000-00006

Long-term bromocriptine therapy may restore the inhibitory control of prolactin release in some patients with pathological hyperprolactinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199902000-00006

A double-blind study comparing a new non-ergot, long-acting dopamine agonist, CV 205-502, with bromocriptine in women with hyperprolactinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199902000-00006

Prolactin Secreting Tumors Endocrine Status before and after Surgery in 33 Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199902000-00006

Diagnosis and management of hormone-secreting pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199902000-00006

A comparison of the efficacy and safety of pergolide and bromocriptine in the treatment of hyperprolactinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199902000-00006

Transsphenoidal adenomectomy for microprolactinomas: 10 to 20 years of follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199902000-00006

Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199902000-00006

Factors in Predicting Outcome from Operation in Patients with Prolactin-secreting Pituitary Adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199902000-00006

Selective Transsphenoidal Adenomectomy in Women With Galactorrhea-Amenorrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199902000-00006

Prolactin-secreting pituitary tumors in amenorrheic women: a comprehensive study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199902000-00006

Ten year follow up of microprolactinoma treated by transsphenoidal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199902000-00006

Long-term Treatment of Galactorrhoea and Hypogonadism with Bromocriptine

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199902000-00006

Galactorrhea-amenorrhea syndrome: follow-up of forty-five patients after pituitary tumor removal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199902000-00006

CV 205–502, a new dopamine agonist, versus bromocriptine in the treatment of hyperprolactinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199902000-00006

Drugs five years later. Bromocriptine

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199902000-00006

Low recurrence rate after partial hypophysectomy for prolactinoma: the predictive value of dynamic prolactin function tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199902000-00006

A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199902000-00006

A decade of pituitary microsurgery. The Herbert Olivecrona lecture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199902000-00006

10.1097/00006123-199902000-00006

21 January 2018

Identifiers

DOI

1 reference

19 December 2017

PubMed ID

9932878

1 reference

19 December 2017